Current treatment options in oncology

Curr Treat Options Oncol · ISSN (e) 1534-6277 · 3 papers in corpus
2025
doi:10.1007/s11864-025-01346-0 ·PMID:40911247

Opinion statementOvarian cancer, particularly high-grade serous carcinoma (HGSC), remains a leading cause of mortality in gynecologic oncology. Emerging research identifies serous tubal intraepithelial carcinoma (STIC) as a precursor lesion…

2023
doi:10.1007/s11864-023-01138-4 ·PMID:37938504

Opinion statementOvarian carcinosarcoma (OCS), also known as a malignant mixed Müllerian tumour (MMMT), is a rare and aggressive form of cancer that accounts for less than 5% of ovarian cancers. It is characterized by high morbidity and mor…

review 2009
doi:10.1007/s11864-009-0108-2 ·PMID:19603272

Ovarian cancer is the deadliest gynecologic cancer. Unlike many cancers such as breast, cervical and colon cancers, there is no easily clinically identifiable pre-malignant phase of this malignancy making early identification difficult. Sim…